A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials

被引:105
作者
Kasarskis, EJ [1 ]
Scarlata, D
Hill, R
Fuller, C
Stambler, N
Cedarbaum, JM
机构
[1] Vet Affairs Med Ctr, Neurol Serv 127, Cooper Dr Div, Lexington, KY 40511 USA
[2] Univ Kentucky, Dept Neurol, Lexington, KY 40511 USA
[3] Univ Kentucky, Dept Toxicol, Lexington, KY 40511 USA
[4] Univ Kentucky, Dept Nutr, Lexington, KY 40511 USA
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
percutaneous endoscopic gastrostomy; amyotrophic lateral sclerosis;
D O I
10.1016/S0022-510X(99)00230-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Percutaneous endoscopic gastrostomy (PEG) provides a reliable route for nutrition and hydration in ALS patients with dysphagia. We performed a retrospective analysis of the CNTF and BDNF databases to determine the clinical status of ALS patients within 30 days preceding PEG insertion. This analysis revealed an approximately 50% reduction of function across multiple measures of ALS disease status. A trend to earlier intervention with PEG was apparent upon review of published studies and the CNTF and BDNF studies. By comparing the rate of decline pre- and post-PEG, nutritional supplementation via PEG stabilized the weight loss experienced by patients. Death within 30 days post-PEG was associated with a marked reduction in forced vital capacity (FVC) and identified a group of ALS patients in whom PEG should be cautiously performed. These data emphasize the importance of sequential measurement of FVC in managing ALS patients to guide the timing of nutritional intervention with PEG. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:118 / 125
页数:8
相关论文
共 31 条
[1]   FEEDING VIA NASOGASTRIC TUBE OR PERCUTANEOUS ENDOSCOPIC GASTROSTOMY - A COMPARISON [J].
BAETEN, C ;
HOEFNAGELS, J .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 :95-98
[3]  
Brooks BR, 1996, NEUROLOGY, V47, pS71, DOI 10.1212/WNL.47.4_Suppl_2.71S
[4]  
Brooks BR, 1996, ARCH NEUROL-CHICAGO, V53, P141
[5]  
Cedarbaum J.M., 1997, J NEUROL SCI S1, V152, P1
[6]  
Chiò A, 1998, NEUROLOGY, V50, pA30
[7]  
COGEN R, 1989, AM J GASTROENTEROL, V84, P1509
[8]  
DAMIANO AM, 1996, QUALITY LIFE PHARMAC, P347
[9]   PERCUTANEOUS ENDOSCOPIC GASTROJEJUNOSTOMY - A DUAL CENTER SAFETY AND EFFICACY TRIAL [J].
DELEGGE, MH ;
DUCKWORTH, F ;
MCHENRY, L ;
FOXXORENSTEIN, A ;
CRAIG, RM ;
KIRBY, DF .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1995, 19 (03) :239-243
[10]   POOR RESULTS WITH PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY [J].
DISARIO, JA ;
FOUTCH, PG ;
SANOWSKI, RA .
GASTROINTESTINAL ENDOSCOPY, 1990, 36 (03) :257-260